| Literature DB >> 31984445 |
S Both1, R J B Van Veen2, M Brom2, P T M Weijenborg2.
Abstract
RATIONALE ANDEntities:
Keywords: Classical conditioning; Learning; Memory consolidation; NMDA; Reward; Sexual arousal
Year: 2020 PMID: 31984445 PMCID: PMC7196949 DOI: 10.1007/s00213-020-05457-4
Source DB: PubMed Journal: Psychopharmacology (Berl) ISSN: 0033-3158 Impact factor: 4.530
Descriptive variables of participants
| Placebo ( | DCS ( | ||||
|---|---|---|---|---|---|
| Mean | SD | Mean | SD | ||
| Age | 23.08 | 4.65 | 23.27 | 2.75 | 0.197 |
| Sexual functioning (FSFI) | 28.36 | 4.44 | 27.02 | 7.29 | 0.135 |
| Prior experience vibrostimulation | 2.50 | 1.25 | 2.92 | 1.47 | 0.484 |
FSFI, Female Sexual Function Index (Ter Kuile et al., 2006). Item from the questionnaire on day 1: Prior experience with vibrostimulation (never (1), very often (5))
Fig. 1Schematic overview of the experimental procedure. During the baseline period, participants watched a neutral movie. The A blocks represent the acquisition context and the B blocks the extinction context. = vibration
Ratings of affect, sexual arousal and US expectancy following the CS+ and CS− on day 1 during the preconditioning phase and at the first and last extinction trial
| Placebo | DCS | Stimulus effect | Group effect | Stimulus X group effect | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean (SD) | 95% CI | Mean (SD) | 95% CI | ||||||||||||
| Pre-conditioning | |||||||||||||||
| Affect | |||||||||||||||
| CS+ | 4.36 (0.60) | 4.18, 4.67 | 24 | 4.53 (0.60) | 4.28, 4.78 | 26 | 1.26 | 0.262 | 0.03 | 2.29 | 0.145 | 0.05 | 0.25 | 0.620 | 0.01 |
| CS− | 4.42 (0.59) | 4.22, 4.78 | 4.62 (0.78) | 4.33, 4.89 | |||||||||||
| Sexual arousal | |||||||||||||||
| CS+ | 3.66 (1.13) | 3.32, 4.20 | 24 | 3.79 (1.09) | 3.35, 4.23 | 26 | 3.64 | 0.062 | 0.07 | 0.36 | 0.553 | 0.01 | 0.37 | 0.548 | 0.01 |
| CS− | 3.77 (1.10) | 3.41, 4.33 | 4.01 (1.23) | 3.55, 4.47 | |||||||||||
| US expectancy | |||||||||||||||
| CS+ | 3.13 (1.05) | 2.72, 3.68 | 24 | 3.22 (1.36) | 2.74, 3.70 | 26 | 1.32 | 0.256 | 0.03 | 0.33 | 0.570 | 0.01 | 1.56 | 0.218 | 0.03 |
| CS− | 3.17 (1.06) | 2.72, 3.96 | 3.48 (1.40) | 2.20, 3.97 | |||||||||||
| First extinction trial | |||||||||||||||
| Affect | |||||||||||||||
| CS+ | 4.71 (0.99) | 4.35, 5.11 | 24 | 4.92 (0.91) | 4.54, 5.31 | 25 | 5.01 | 0.029 | 0.10 | 2.77 | 0.103 | 0.06 | 1.18 | 0.282 | 0.09 |
| CS− | 4.25 (0.74) | 4.01, 4.69 | 4.76 (0.93) | 4.41, 5.12 | |||||||||||
| Sexual arousal | |||||||||||||||
| CS+ | 4.29 (1.60) | 3.82, 4.95 | 24 | 4.32 (1.25) | 3.75, 4.89 | 25 | 1.27 | 0.266 | 0.03 | 0.09 | 0.765 | 0.00 | 0.08 | 0.780 | 0.00 |
| CS− | 3.96 (1.33) | 3.52, 4.56 | 4.12 (1.33) | 3.59, 4.65 | |||||||||||
| US expectancy | |||||||||||||||
| CS+ | 4.26 (1.91) | 3.52, 4.96 | 23 | 4.00 (1.76) | 3.28, 4.72 | 25 | 9.49 | 0.003 | 0.17 | 0.06 | 0.811 | 0.00 | 0.22 | 0.642 | 0.01 |
| CS− | 2.96 (1.89) | 2.40, 3.84 | 3.04 (1.65) | 2.32, 3.76 | |||||||||||
| Last extinction trial | |||||||||||||||
| Affect | |||||||||||||||
| CS+ | 4.46 (1.14) | 3.12, 4.05 | 24 | 3.54 (1.32) | 3.02, 4.06 | 24 | 0.00 | 1.00 | 0.00 | 0.06 | 0.799 | 0.00 | 0.00 | 1.00 | 0.00 |
| CS− | 3.46 (1.06) | 3.11, 4.10 | 3.54 (1.25) | 3.05, 4.03 | |||||||||||
| Sexual Arousal | |||||||||||||||
| CS+ | 2.46 (1.47) | 1.97, 3.10 | 24 | 2.79 (1.41) | 2.20, 3.38 | 24 | 0.07 | 0.784 | 0.00 | 1.61 | 0.210 | 0.03 | 1.21 | 0.277 | 0.03 |
| CS− | 2.25 (1.42) | 1.77, 2.93 | 2.92 (1.53) | 2.31, 3.52 | |||||||||||
| US expectancy | |||||||||||||||
| CS+ | 1.67 (1.20) | 1.18, 2.18 | 24 | 1.67 (1.2) | 1.16, 2.18 | 24 | 0.02 | 0.903 | 0.00 | 0.55 | 0.462 | 0.01 | 1.79 | 0.186 | 0.04 |
| CS− | 1.46 (0.93) | 1.00, 1.96 | 1.92 (1.41) | 1.43, 2.40 | |||||||||||
Ratings represent the following: extremely unpleasant (1) to extremely pleasant (7) for affective value, not sexually arousing at all (1) to very strongly sexually arousing (7) for sexual arousal and certainly no vibration (1) to certainly a vibration (7) for US expectancy
Fig. 2Mean affect ratings (± SEM) on day 2 following CS+ and CS− for the placebo and DCS condition per context, context A represents the acquisition context and context B the extinction context
Fig. 3Mean sexual arousal ratings (± SEM) on day 2 following CS+ and CS− for the placebo and DCS condition per context, context A represents the acquisition context and context B the extinction context
Fig. 4Mean US expectancy ratings (± SEM) at day 2 following CS+ and CS− for the placebo and DCS condition per context, context A represents the acquisition context and context B the extinction context